FDA.reportPublic FDA data

Nesina 6.25 MG (as alogliptin benzoate 8.5 MG) Oral Tablet

RxCUI
1368020
RxNorm name
Nesina 6.25 MG (as alogliptin benzoate 8.5 MG) Oral Tablet
Display name
Nesina 6.25 MG (as alogliptin benzoate 8.5 MG) Oral Tablet
Full name
Nesina 6.25 MG (as alogliptin benzoate 8.5 MG) Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:12

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
NesinaALOGLIPTINTakeda Pharmaceuticals America, Inc.a3768c7e-aa4c-44d3-bc53-43bb7346c0b02025-02-28Warnings, Adverse reactionsExact identifier
rxcui: 1368020

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
a3768c7e-aa4c-44d3-bc53-43bb7346c0b0Nesina 6.25 MG Oral Tablet [PSN] · alogliptin 6.25 MG Oral Tablet [Nesina] [SBD] · Nesina 6.25 MG (as alogliptin benzoate 8.5 MG) Oral Tablet [SY] · Nesina 6.25 MG Oral Tablet [SY]422These highlights do not include all the information needed to use NESINA ® safely and effectively. See full prescribing information for NESINA. NESINA (alogliptin) tablets, for oral use Initial U.S. Approval: 201320250228